
  
    
      
        Background_NNP
        The_DT ubiquitin_NN /_NN proteasome-dependent_JJ proteolysis_NNS system_NN
        has_VBZ been_VBN implicated_VBN in_IN a_DT wide_JJ variety_NN of_IN cellular_JJ
        regulatory_JJ mechanisms_NNS ,_, including_VBG transcription_NN ,_, signal_NN
        transduction_NN ,_, and_CC cell_NN cycle_NN control_NN (_( reviewed_VBN in_IN [_NN 1_CD ]_NN )_) ._.
        The_DT system_NN employs_VBZ a_DT cascade_NN of_IN enzymatic_JJ reactions_NNS that_WDT
        lead_VBP to_TO the_DT covalent_NN attachment_NN of_IN a_DT chain_NN of_IN multiple_JJ
        ubiquitins_NNS to_TO substrate_NN proteins_NNS [_NN 2_CD ]_NN ._. In_IN many_JJ cases_NNS ,_,
        modification_NN by_IN ubiquityl_NN moieties_NNS targets_NNS proteins_NNS to_TO the_DT
        proteasome_NN ,_, ultimately_RB resulting_VBG in_IN their_PRP$ degradation_NN ._. The_DT
        ubiquitylation_NN reaction_NN involves_VBZ a_DT minimum_NN of_IN three_CD
        enzymes_NNS :_: An_DT E_NNP 1_CD ,_, which_WDT mediates_NNS the_DT ATP-dependent_NNP activation_NN
        of_IN ubiquitin_NN ,_, and_CC an_DT E_NNP 2_CD ,_, or_CC ubiquitin_NN conjugating_VBG enzyme_NN
        (_( UBC_NNP )_) ,_, which_WDT ,_, together_RB with_IN an_DT E_NNP 3_CD ubiquitin_NN ligase_NN ,_,
        transfers_NNS ubiquitin_NN to_TO the_DT target_NN protein_NN ._. E_NNP 3_CD enzymes_NNS are_VBP
        of_IN particular_JJ interest_NN ,_, as_IN they_PRP mediate_VB the_DT substrate_NN
        specificity_NN of_IN ubiquitylation_NN reactions_NNS ._.
        Studies_NNS in_IN budding_VBG yeast_NN identified_VBD SCF_NNP Cdc_NNP 4_CD p_NN ,_, an_DT E_NNP 3_CD
        ubiquitin_NN ligase_NN complex_JJ that_IN mediates_NNS the_DT ubiquitylation_NN
        of_IN the_DT CDK_NNP inhibitor_NN Sic_NNP 1_CD p_NN [_NN 3_CD 4_CD ]_NN ._. SCF_NNP Cdc_NNP 4_CD pconsists_NNS of_IN
        at_IN least_JJS four_CD proteins_NNS :_: the_DT cullin_NN Cdc_NNP 53_CD p_NN ,_, the_DT RING_NNP domain_NN
        protein_NN Hrt_NNP 1_CD p_NN /_NN Rbx_NNP 1_CD p_NN /_NN Roc_NNP 1_CD p_NN ,_, the_DT adapter_NN protein_NN Skp_NNP 1_CD p_NN ,_, and_CC
        Cdc_NNP 4_CD p_NN (_( reviewed_VBN in_IN [_NN 1_CD ]_NN )_) ._. Cdc_NNP 4_CD p_NN contains_VBZ two_CD sequence_NN
        motifs_NNS ,_, which_WDT are_VBP conserved_JJ in_IN a_DT wide_JJ variety_NN of_IN so-called_JJ
        F-_NNP box_NN proteins_NNS :_: C-_NNP terminal_NN WD-repeats_NNP that_WDT are_VBP involved_VBN in_IN
        binding_VBG the_DT substrate_NN Sic_NNP 1_CD p_NN in_IN a_DT phosphorylation-dependent_JJ
        manner_NN ,_, and_CC a_DT central_JJ F-_NNP box_NN [_NN 5_CD ]_NN that_IN interacts_NNS with_IN Skp_NNP 1_CD p_NN
        [_NN 6_CD 7_CD ]_NN ._. Cdc_NNP 53_CD p_NN in_IN turn_NN binds_NNS to_TO Skp_NNP 1_CD p_NN and_CC
        Hrt_NNP 1_CD p_NN /_NN Rbx_NNP 1_CD p_NN /_NN Roc_NNP 1_CD p_NN ,_, which_WDT bridges_NNS Cdc_NNP 53_CD p_NN with_IN the_DT
        ubiquitin-conjugating_JJ enzyme_NN Cdc_NNP 34_CD p_NN /_NN Ubc_NNP 3_CD p_NN [_NN 6_CD 8_CD 9_CD 10_CD 11_CD 12_CD
        ]_NN ._. 
        In_IN vitro_NN reconstitution_NN demonstrated_VBN
        that_IN SCF_NNP Cdc_NNP 4_CD p_NN ,_, Cdc_NNP 34_CD p_NN ,_, E_NNP 1_CD ,_, ubiquitin_NN ,_, and_CC ATP_NNP are_VBP
        sufficient_JJ to_TO mediate_VB Sic_NNP 1_CD p_NN polyubiquitylation_NN [_NN 6_CD 7_CD ]_NN
        ._.
        Components_NNP of_IN the_DT SCF_NNP system_NN are_VBP widely_RB conserved_JJ in_IN
        eukaryotes_NNS [_NN 1_CD 3_CD ]_NN ._. In_IN human_JJ cells_NNS ,_, for_IN example_NN ,_, SCF_NNP
        Skp_NNP 2_CD mediates_NNS destruction_NN of_IN the_DT CDK_NNP inhibitor_NN p_NN 27_CD [_NN 13_CD 14_CD ]_NN
        ,_, while_IN SCF_NNP β-_NN TRCPtargets_NNP IκB_NNP [_NN 15_CD 16_CD 17_CD ]_NN ._. All_DT of_IN these_DT
        SCF_NNP complexes_NNS share_VBP homologues_NNS of_IN the_DT core_NN components_NNS
        CDC_NNP 53_CD /_NN CUL_NNP 1_CD ,_, SKP_NNP 1_CD ,_, and_CC HRT_NNP 1_CD /_NN RBX_NNP 1_CD /_NN ROC_NNP 1_CD ,_, which_WDT associate_JJ with_IN
        different_JJ F-_NNP box_NN proteins_NNS ._.
        Several_JJ lines_NNS of_IN evidence_NN suggest_VBP that_IN the_DT SCF_NNP pathway_NN
        is_VBZ also_RB conserved_JJ in_IN the_DT fission_NN yeast_NN 
        Schizosaccharomyces_NNP pombe_NN ._. Pcu_NNP 1_CD p_NN ,_, a_DT
        Cdc_NNP 53_CD p_NN /_NN CUL_NNP 1_CD -_: related_VBN protein_NN ,_, was_VBD shown_VBN to_TO associate_JJ with_IN
        two_CD different_JJ F-_NNP box_NN /_NN WD_NNP repeat_NN proteins_NNS ,_, Pop_NNP 1_CD p_NN and_CC Pop_NNP 2_CD p_NN ,_,
        when_WRB overexpressed_JJ [_NN 18_CD ]_NN ._. In_IN addition_NN ,_, genetic_JJ studies_NNS
        demonstrated_VBN that_IN both_DT of_IN these_DT F-_NNP box_NN proteins_NNS are_VBP
        simultaneously_RB required_VBN for_IN efficient_JJ destruction_NN of_IN Rum_NNP 1_CD p_NN
        and_CC the_DT replication_NN initiator_NN Cdc_NNP 18_CD p_NN [_NN 18_CD 19_CD 20_CD ]_NN ._. Rum_NNP 1_CD p_NN
        is_VBZ a_DT Sic_NNP 1_CD p-analogous_JJ CDK_NNP inhibitor_NN ,_, which_WDT accumulates_NNS in_IN
        G_NNP 1_CD ,_, but_CC is_VBZ degraded_JJ as_IN cells_NNS enter_VBP S_NNP phase_NN [_NN 21_CD 22_CD ]_NN ._.
        Failure_NN to_TO degrade_NN Rum_NNP 1_CD p_NN is_VBZ the_DT major_JJ phenotypic_JJ defect_NN of_IN 
        pop_NN 1_CD and_CC 
        pop_NN 2_CD deletion_NN strains_NNS ,_, which_WDT leads_VBZ to_TO
        disturbance_NN of_IN normal_JJ cell_NN cycle_NN progression_NN ,_, resulting_VBG in_IN
        polyploidy_NN [_NN 18_CD 19_CD 20_CD 23_CD ]_NN ._. Based_VBN on_IN the_DT genetic_JJ data_NN and_CC
        the_DT biochemical_JJ observation_NN that_IN Pop_NNP 1_CD p_NN and_CC Pop_NNP 2_CD p_NN interact_NN
        when_WRB overexpressed_JJ ,_, a_DT putative_JJ SCF_NNP Pop_NNP 1_CD p-_NN Pop_NNP 2_CD pcomplex_NN was_VBD
        proposed_VBN ,_, which_WDT would_MD contain_VB the_DT heterooligomerizing_VBG F-_NNP box_NN
        proteins_NNS Pop_NNP 1_CD p_NN and_CC Pop_NNP 2_CD p_NN bound_VBN to_TO SCF_NNP core_NN components_NNS [_NN 18_CD
        20_CD ]_NN ._.
        Whether_IN this_DT unusual_JJ heterooligomeric_JJ SCF_NNP
        Pop_NNP 1_CD p-_NN Pop_NNP 2_CD pcomplex_NN exists_VBZ 
        in_IN vivo_NN and_CC whether_IN it_PRP mediates_NNS Rum_NNP 1_CD p_NN
        ubiquitylation_NN ,_, remained_VBD unproven_JJ ,_, as_IN not_RB all_DT fission_NN yeast_NN
        SCF_NNP core_NN subunits_NNS were_VBD identified_VBN ._. In_IN addition_NN ,_, based_VBN on_IN
        overexpression_NN ,_, distinct_JJ SCF_NNP Pop_NNP 1_CD pand_NN SCF_NNP Pop_NNP 2_CD pcomplexes_NNS
        were_VBD proposed_VBN to_TO target_VB unknown_JJ substrates_NNS ,_, but_CC no_DT
        biochemical_JJ evidence_NN of_IN their_PRP$ activity_NN was_VBD provided_VBN [_NN 18_CD ]_NN
        ._. To_TO address_VB these_DT questions_NNS ,_, we_PRP cloned_VBN two_CD additional_JJ
        subunits_NNS of_IN SCF_NNP Popand_NNP performed_VBD a_DT detailed_VBN
        characterization_NN of_IN its_PRP$ activity_NN 
        in_IN vitro_NN and_CC 
        in_IN vivo_NN ._. Our_PRP$ results_NNS indicate_VBP that_IN
        heterooligomeric_JJ SCF_NNP Pop_NNP 1_CD p-_NN Pop_NNP 2_CD pmediates_NNS Rum_NNP 1_CD p_NN
        ubiquitylation_NN whereas_IN distinct_JJ SCF_NNP Pop_NNP 1_CD pand_NN SCF_NNP
        Pop_NNP 2_CD pcomplexes_NNS target_VBP unknown_JJ nuclear_JJ and_CC cytoplasmic_JJ
        substrates_NNS ,_, thereby_RB generating_NN combinatorial_NN diversity_NN of_IN
        SCF_NNP function_NN in_IN fission_NN yeast_NN ._.
      
      
        Results_NNS
        
          Composition_NNP of_IN SCF_NNP Pop_NNP 1_CD p-_NN Pop_NNP 2_CD p_NN
          Based_VBN on_IN the_DT composition_NN of_IN known_VBN SCF_NNP complexes_NNS ,_, we_PRP
          identified_VBD in_IN the_DT 
          S_NNP ._. pombe_NN genome_NN database_NN 
          psh_NN 1_CD (_( pombe_NN skp_NN 1_CD homologue_NN )_) and_CC 
          pip_NN 1_CD (_( pop_NN interacting_VBG protein_NN 1_LS )_) ,_,
          two_CD genes_NNS encoding_VBG proteins_NNS with_IN strong_JJ similarity_NN to_TO
          human_JJ SKP_NNP 1_CD and_CC HRT_NNP 1_CD /_NN RBX_NNP 1_CD /_NN ROC_NNP 1_CD ,_, respectively_RB (_( data_NNS not_RB
          shown_VBN )_) ._. Consistent_NNP with_IN these_DT proteins_NNS being_VBG components_NNS
          of_IN the_DT putative_JJ SCF_NNP Pop_NNP 1_CD p-_NN Pop_NNP 2_CD pcomplex_NN ,_, they_PRP all_DT
          co-purified_JJ with_IN Pop_NNP 1_CD p_NN ,_, Pop_NNP 2_CD p_NN ,_, and_CC Pcu_NNP 1_CD p_NN when_WRB
          overexpressed_JJ pairwise_NN (_( data_NNS not_RB shown_VBN )_) ._.
          Co-immunoprecipitation_NNP experiments_NNS using_VBG affinity_NN
          purified_JJ rabbit_NN antisera_NN confirmed_VBD these_DT interactions_NNS at_IN
          the_DT level_NN of_IN the_DT endogenous_JJ proteins_NNS ._. While_IN each_DT of_IN the_DT
          five_CD antisera_NN co-precipitated_JJ at_IN least_JJS one_CD of_IN the_DT other_JJ
          subunits_NNS ,_, Pip_NNP 1_CD p_NN ,_, Pop_NNP 1_CD p_NN ,_, and_CC Pop_NNP 2_CD p_NN antisera_NN
          co-precipitated_JJ all_DT five_CD proteins_NNS from_IN wild-type_JJ cell_NN
          lysate_NN (_( Fig_NNP ._. 1_LS A_DT )_) ._. Size_NN fractionation_NN of_IN total_JJ cell_NN
          lysates_NNS prior_RB to_TO immunoprecipitation_NN revealed_VBD co-elution_JJ
          of_IN Pip_NNP 1_CD p_NN with_IN Pop_NNP 1_CD p_NN ,_, Pop_NNP 2_CD p_NN ,_, Pcu_NNP 1_CD p_NN ,_, and_CC Psh_NNP 1_CD p_NN in_IN a_DT high_JJ
          molecular_JJ weight_NN complex_NN of_IN approximately_RB 500_CD kDa_NN ,_, which_WDT
          we_PRP refer_VBP to_TO as_IN SCF_NNP Pop_NNP 1_CD p-_NN Pop_NNP 2_CD p_NN (_( Fig_NNP ._. 1_LS B_NNP )_) ._. The_DT composition_NN
          of_IN the_DT core_NN complex_JJ Pip_NNP 1_CD p_NN /_NN Pcu_NNP 1_CD p_NN /_NN Psh_NNP 1_CD p_NN did_VBD not_RB undergo_VB
          major_JJ variations_NNS during_IN the_DT cell_NN cycle_NN (_( Fig_NNP ._. 1_LS C_NNP )_) ._. We_PRP have_VBP
          carefully_RB reexamined_JJ potential_JJ cell_NN cycle_NN variations_NNS of_IN
          Pcu_NNP 1_CD p_NN neddylation_NN apparent_JJ in_IN the_DT IP_NNP /_NN immunoblotting_VBG
          experiment_NN in_IN Fig_NNP ._. 1_LS C_NNP ._. These_DT variations_NNS were_VBD not_RB seen_VBN
          when_WRB samples_NNS were_VBD denatured_JJ in_IN SDS_NNP immediately_RB following_VBG
          extract_NN preparation_NN (_( data_NNS not_RB shown_VBN )_) ,_, suggesting_VBG that_IN
          they_PRP arise_VBP from_IN varying_VBG degrees_NNS of_IN deneddylation_NN
          presumably_RB occuring_VBG during_IN the_DT immunoprecipitation_NN step_NN ._.
          In_IN addition_NN ,_, in_IN a_DT separate_JJ experiment_NN ,_, Pop_NNP 1_CD p-_NN Pop_NNP 2_CD p_NN
          heterooligomerization_NN was_VBD largely_RB constant_JJ during_IN the_DT
          cell_NN cycle_NN (_( Fig_NNP ._. 1_LS C_NNP )_) ._. These_DT findings_NNS indicated_VBD that_DT cell_NN
          cycle-dependent_JJ substrate_NN degradation_NN is_VBZ unlikely_JJ to_TO be_VB
          controlled_VBN at_IN the_DT level_NN of_IN SCF_NNP Pop_NNP 1_CD p-_NN Pop_NNP 2_CD pcomplex_NN
          formation_NN ._.
        
        
          SCF_NNP Pop_NNP 1_CD p-_NN Pop_NNP 2_CD pmediates_NNS polyubiquitylation_NN of_IN Rum_NNP 1_CD p_NN
          in_IN vitro_NN
          Genetic_JJ experiments_NNS suggested_VBD that_DT degradation_NN of_IN
          Rum_NNP 1_CD p_NN depends_VBZ on_IN the_DT Pop_NNP 1_CD p_NN and_CC Pop_NNP 2_CD p_NN F-_NNP box_NN proteins_NNS [_NN 18_CD
          20_CD ]_NN ,_, but_CC also_RB requires_VBZ phosphorylation_NN of_IN Rum_NNP 1_CD p_NN on_IN
          serine_NN 58_CD and_CC threonine_NN 62_CD by_IN cyclin-dependent_JJ kinase_NN
          (_( CDK_NNP )_) [_NN 21_CD ]_NN ._. Thus_RB ,_, phosphorylated_JJ Rum_NNP 1_CD p_NN may_MD be_VB a_DT
          substrate_NN for_IN SCF_NNP Pop_NNP 1_CD p-_NN Pop_NNP 2_CD p-mediated_JJ
          polyubiquitylation_NN ._. To_TO test_VB this_DT ,_, we_PRP first_RB confirmed_VBD that_IN
          Rum_NNP 1_CD p_NN is_VBZ an_DT 
          in_IN vitro_NN substrate_NN for_IN the_DT Cdc_NNP 2_CD p_NN
          kinase_NN in_IN association_NN with_IN the_DT cyclin_NN Cig_NNP 1_CD p_NN [_NN 21_CD ]_NN as_IN
          judged_VBN by_IN a_DT mobility_NN shift_NN on_IN SDS_NNP gels_NNS (_( Fig_NNP ._. 2_LS A_DT )_) ._.
          Bacterially_NNP expressed_VBD Rum_NNP 1_CD p_NN purified_JJ to_TO apparent_JJ
          homogeneity_NN was_VBD also_RB efficiently_RB phosphorylated_JJ by_IN
          Cdc_NNP 2_CD p_NN /_NN Cig_NNP 1_CD p_NN complexes_NNS (_( Fig_NNP ._. 2_LS A_DT )_) ._.
          To_TO determine_VB whether_IN phosphorylated_JJ Rum_NNP 1_CD p_NN interacts_NNS
          with_IN Pop_NNP 1_CD p_NN and_CC Pop_NNP 2_CD p_NN ,_, protein_NN lysate_NN was_VBD prepared_VBN from_IN
          cells_NNS co-overexpressing_JJ epitope-tagged_JJ combinations_NNS of_IN
          Pop_NNP 1_CD p_NN and_CC Pop_NNP 2_CD p_NN ._. Upon_IN affinity_NN purification_NN on_IN Ni-_NNP NTA_NNP
          resin_NN ,_, HA-Pop_NNP 1_CD p_NN /_NN His-_NNP Myc-_NNP Pop_NNP 2_CD p_NN complexes_NNS were_VBD incubated_JJ
          with_IN bacterially_RB expressed_VBD ,_, phosphorylated_JJ Rum_NNP 1_CD p_NN ._. In_IN this_DT
          reaction_NN ,_, Pop_NNP 1_CD p-_NN Pop_NNP 2_CD p_NN complexes_NNS specifically_RB bound_VBN
          phosphorylated_JJ Rum_NNP 1_CD p_NN (_( Fig_NNP ._. 2_LS B_NNP ,_, lane_NN 1_LS )_) ._. Consistent_NNP with_IN
          the_DT genetic_JJ data_NN [_NN 20_CD ]_NN ,_, His-_NNP Myc-_NNP Pop_NNP 1_CD p_NN and_CC His-_NNP Myc-_NNP Pop_NNP 2_CD p_NN
          individually_RB purified_JJ upon_IN overexpression_NN in_IN 
          pop_NN 1_CD pop_NN 2_CD double_JJ mutants_NNS exhibited_VBN
          no_DT Rum_NNP 1_CD p_NN binding_JJ above_IN background_NN (_( Fig_NNP ._. 2_LS B_NNP ,_, lanes_NNS 2_CD and_CC
          3_LS )_) ._.
          Given_VBN our_PRP$ ability_NN to_TO prepare_VB immunopurified_JJ SCF_NNP
          Pop_NNP 1_CD p-_NN Pop_NNP 2_CD pthat_NN bound_VBN phosphorylated_JJ Rum_NNP 1_CD p_NN ,_, we_PRP sought_VBD to_TO
          reconstitute_NN Rum_NNP 1_CD p_NN polyubiquitylation_NN 
          in_IN vitro_NN ._. In_IN addition_NN ,_, we_PRP required_VBD
          an_DT ubiquitin_NN activating_VBG enzyme_NN (_( E_NNP 1_LS )_) and_CC an_DT ubiquitin_NN
          conjugating_VBG enzyme_NN (_( UBC_NNP )_) ._. While_IN human_JJ E_NNP 1_CD is_VBZ highly_RB
          similar_JJ to_TO its_PRP$ fission_NN yeast_NN counterpart_NN (_( data_NNS not_RB
          shown_VBN )_) ,_, inspection_NN of_IN the_DT 
          S_NNP ._. pombe_NN genome_NN revealed_VBD fourteen_CD
          potential_JJ UBCs_NNP ,_, none_NN of_IN which_WDT is_VBZ an_DT obvious_JJ homologue_NN of_IN
          human_JJ UBC_NNP 3_CD or_CC budding_VBG yeast_NN Cdc_NNP 34_CD p_NN ,_, since_IN all_DT lack_NN the_DT
          characteristic_JJ C-_NNP terminal_NN extension_NN (_( data_NNS not_RB shown_VBN )_) ._. We_PRP
          therefore_RB purified_JJ recombinant_JJ human_JJ E_NNP 1_CD and_CC UBC_NNP 3_CD (_( CDC_NNP 34_CD )_)
          upon_IN expression_NN in_IN bacteria_NNS (_( Fig_NNP ._. 2_LS C_NNP )_) ._.
          In_IN the_DT presence_NN of_IN human_JJ E_NNP 1_CD ,_, UBC_NNP 3_CD ,_, ubiquitin_NN ,_, and_CC ATP_NNP ,_,
          SCF_NNP Pop_NNP 1_CD p-_NN Pop_NNP 2_CD pcomplexes_NNS immunopurified_JJ with_IN Pip_NNP 1_CD p_NN
          antibodies_NNS converted_VBD a_DT small_JJ portion_NN of_IN phosphorylated_JJ
          Rum_NNP 1_CD p_NN into_IN high_JJ molecular_JJ weight_NN species_NNS (_( Fig_NNP ._. 2_LS D_NNP )_) ._. This_DT
          conversion_NN was_VBD dependent_JJ on_IN the_DT addition_NN of_IN E_NNP 1_CD ,_, ATP_NNP (_( data_NNS
          not_RB shown_VBN )_) ,_, and_CC wild-type_JJ UBC_NNP 3_CD (_( Fig_NNP ._. 2_LS D_NNP ,_, lanes_NNS 2_CD ,_, 4_CD ,_, 6_CD )_) ._.
          The_DT activity_NN of_IN SCF_NNP Pop_NNP 1_CD p_NN /_NN Pop_NNP 2_CD pwas_NNS augmented_JJ when_WRB Pip_NNP 1_CD p_NN
          complexes_NNS where_WRB purified_JJ from_IN 
          csn_NN 5_CD mutants_NNS (_( Fig_NNP ._. 2_LS D_NNP ,_, lane_NN 5_LS )_) ._.
          This_DT mutant_JJ accumulates_NNS Pcu_NNP 1_CD p_NN exclusively_RB in_IN a_DT form_NN
          carrying_VBG the_DT stimulatory_NN Nedd_NNP 8_CD p_NN modification_NN ,_, due_JJ to_TO a_DT
          defect_NN in_IN COP_NNP 9_CD /_NN signalosome-mediated_JJ cullin_NN deneddylation_NN
          [_NN 24_CD 25_CD ]_NN ._. Replacing_VBG wild-type_JJ ubiquitin_NN by_IN a_DT mutant_JJ
          lacking_VBG all_DT lysine_NN residues_NNS prevented_VBD the_DT formation_NN of_IN
          high_JJ molecular_JJ weight_NN products_NNS (_( Fig_NNP ._. 2_LS D_NNP ,_, lane_NN 7_CD )_) ,_,
          indicating_VBG that_IN they_PRP represent_VBP polyubiquitylated_JJ Rum_NNP 1_CD p_NN
          species_NNS generated_VBN in_IN the_DT reaction_NN ._. Similar_JJ
          polyubiquitylated_JJ reaction_NN products_NNS were_VBD detected_VBN upon_IN
          incubation_NN of_IN phosphorylated_JJ Rum_NNP 1_CD p_NN with_IN Pcu_NNP 1_CD p_NN
          immunocomplexes_NNS ,_, further_JJ suggesting_VBG that_IN the_DT activity_NN is_VBZ
          mediated_JJ by_IN SCF_NNP Pop_NNP 1_CD p-_NN Pop_NNP 2_CD p_NN (_( data_NNS not_RB shown_VBN )_) ._. Moreover_RB ,_,
          Rum_NNP 1_CD p_NN ubiquitylation_NN was_VBD not_RB obtained_VBN with_IN Pip_NNP 1_CD p_NN
          complexes_NNS prepared_VBN from_IN cell_NN lysate_NN of_IN 
          pop_NN 2_CD deletion_NN strains_NNS ,_, proving_VBG the_DT
          F-_NNP box_NN protein_NN dependency_NN of_IN this_DT reaction_NN (_( Fig_NNP ._. 2_LS D_NNP ,_, lane_NN
          3_LS )_) ._. In_IN addition_NN ,_, the_DT reaction_NN was_VBD specific_JJ for_IN human_JJ
          UBC_NNP 3_CD ,_, as_IN no_DT ubiquitylation_NN was_VBD obtained_VBN with_IN fission_NN
          yeast_NN Ubc_NNP 1_CD p_NN ,_, Ubc_NNP 7_CD p_NN ,_, Ubc_NNP 11_CD p_NN ,_, or_CC Ubc_NNP 13_CD p_NN (_( Fig_NNP ._. 2_LS ,_, lanes_NNS
          10_CD ,_, 11_CD )_) ._. Taken_VBN together_RB these_DT results_NNS strongly_RB suggest_VBP
          that_IN SCF_NNP Pop_NNP 1_CD p-_NN Pop_NNP 2_CD pmediates_NNS the_DT polyubiquitylation_NN of_IN
          CDK_NNP phosphorylated_JJ Rum_NNP 1_CD p_NN 
          in_IN vitro_NN ._.
        
        
          Differential_NNP subcellular_NN localization_NN of_IN SCF_NNP
          Pop_NNP 1_CD p-_NN Pop_NNP 2_CD psubunits_NNS
          The_DT co-purification_JJ of_IN the_DT five_CD identified_VBN SCF_NNP
          Pop_NNP 1_CD p-_NN Pop_NNP 2_CD psubunits_NNS and_CC their_PRP$ 
          in_IN vitro_NN activity_NN toward_IN Rum_NNP 1_CD p_NN
          suggested_VBD that_IN they_PRP coexist_NN in_IN a_DT common_JJ subcellular_NN
          compartment_NN ._. The_DT nuclear_JJ localization_NN of_IN the_DT only_RB known_VBN
          substrates_NNS ,_, Cdc_NNP 18_CD p_NN [_NN 26_CD ]_NN and_CC Rum_NNP 1_CD p_NN (_( D_NNP ._. A_DT ._. W_NNP ._. ,_,
          unpublished_JJ )_) ,_, indicated_VBD that_IN a_DT substantial_JJ portion_NN of_IN SCF_NNP
          Pop_NNP 1_CD p-_NN Pop_NNP 2_CD pis_NNS enriched_JJ in_IN the_DT nucleus_NN ._. To_TO test_VB this_DT
          assumption_NN ,_, all_DT five_CD SCF_NNP Pop_NNP 1_CD p-_NN Pop_NNP 2_CD psubunits_NNS were_VBD
          expressed_VBN as_IN fusion_NN proteins_NNS with_IN green_JJ fluorescent_NN
          protein_NN (_( GFP_NNP )_) at_IN low_JJ levels_NNS from_IN an_DT inducible_JJ pRep_NN 81_CD
          plasmid_NN ._. While_IN Pip_NNP 1_CD p_NN ,_, Psh_NNP 1_CD p_NN ,_, Pcu_NNP 1_CD p_NN ,_, and_CC Pop_NNP 2_CD p_NN were_VBD
          present_JJ in_IN both_DT the_DT cytoplasm_NN and_CC the_DT nucleus_NN ,_,
          surprisingly_RB ,_, GFP-Pop_NNP 1_CD p_NN was_VBD largely_RB restricted_VBN to_TO the_DT
          nucleus_NN (_( Fig_NNP ._. 3_LS A_DT )_) ._. These_DT localization_NN patterns_NNS were_VBD
          consistently_RB observed_VBN in_IN each_DT single_JJ cell_NN of_IN an_DT
          asynchronous_JJ population_NN ,_, excluding_VBG major_JJ variations_NNS
          during_IN the_DT cell_NN cycle_NN ._.
          To_TO rule_VB out_RP the_DT possibility_NN that_DT overexpression_NN or_CC
          N-_NNP terminal_NN fusion_NN to_TO GFP_NNP affects_VBZ their_PRP$ localization_NN ,_,
          Pop_NNP 1_CD p_NN and_CC Pop_NNP 2_CD p_NN were_VBD modified_VBN with_IN 13_CD C-_NNP terminal_NN Myc_NNP
          epitope-tags_JJ at_IN the_DT endogenous_JJ genomic_JJ locus_JJ ._.
          Immunoblotting_NNP proved_VBD the_DT expression_NN of_IN correctly_RB sized_VBD
          proteins_NNS and_CC ,_, in_IN addition_NN ,_, showed_VBD that_IN endogenous_JJ Pop_NNP 1_CD p_NN
          is_VBZ approximately_RB twofold_NN more_RBR abundant_JJ in_IN 
          S_NNP ._. pombe_NN cells_NNS than_IN Pop_NNP 2_CD p_NN (_( Fig_NNP ._.
          3_LS B_NNP )_) ._. Indirect_JJ immunofluorescence_NN staining_VBG with_IN Myc_NNP
          antibodies_NNS confirmed_VBD that_IN Pop_NNP 1_CD p_NN is_VBZ predominantly_RB
          localized_VBN to_TO cell_NN nuclei_NN ,_, whereas_IN Pop_NNP 2_CD p_NN is_VBZ expressed_VBN in_IN
          both_DT the_DT cytoplasm_NN and_CC the_DT nucleus_NN (_( Fig_NNP ._. 3_LS C_NNP )_) ._.
          To_TO confirm_VB these_DT localization_NN patterns_NNS ,_, cells_NNS derived_VBN
          from_IN the_DT epitope-tagged_JJ strains_NNS were_VBD biochemically_RB
          fractionated_JJ into_IN cytoplasmic_JJ and_CC nuclear_JJ components_NNS ._. The_DT
          efficiency_NN of_IN enrichment_NN of_IN nuclear_JJ and_CC cytoplasmic_JJ
          components_NNS was_VBD estimated_VBN by_IN analyzing_VBG fractions_NNS with_IN
          antibodies_NNS recognizing_VBG the_DT nuclear_JJ marker_NN PCNA_NNP and_CC
          cytoplasmic_JJ tubulin_NN (_( Fig_NNP ._. 3_LS D_NNP )_) ._. Although_IN both_DT fractions_NNS
          showed_VBD some_DT contamination_NN ,_, Pop_NNP 1_CD p_NN was_VBD detected_VBN mostly_RB in_IN
          nuclear_JJ fractions_NNS ,_, while_IN Pop_NNP 2_CD p_NN was_VBD apparent_JJ in_IN both_DT
          nuclear_JJ and_CC cytoplasmic_JJ fractions_NNS (_( Fig_NNP ._. 3_LS D_NNP )_) ._. Thus_RB ,_, all_DT
          five_CD SCF_NNP Pop_NNP 1_CD p-_NN Pop_NNP 2_CD psubunits_NNS appear_VBP to_TO coexist_NN in_IN the_DT
          nucleus_NN ,_, although_IN all_DT but_CC Pop_NNP 1_CD p_NN are_VBP also_RB present_JJ in_IN the_DT
          cytoplasm_NN ._.
          Since_IN Pop_NNP 1_CD p_NN and_CC Pop_NNP 2_CD p_NN interact_NN with_IN each_DT other_JJ [_NN 20_CD ]_NN
          ,_, we_PRP asked_VBD whether_IN their_PRP$ localization_NN patterns_NNS depended_VBD
          on_IN the_DT presence_NN of_IN the_DT respective_JJ interaction_NN partner_NN ._.
          For_IN this_DT ,_, we_PRP created_VBD a_DT 
          pop_NN 2_CD deletion_NN strain_NN carrying_VBG Pop_NNP 1_CD p_NN
          modified_VBN with_IN 13_CD Myc_NNP epitope_NN tags_NNS at_IN the_DT endogenous_JJ
          genomic_JJ locus_JJ (_( 
          pop_NN 1_CD -_: 13_CD myc_NN Δpop_NN 2_CD strain_NN )_) ._. In_IN
          addition_NN ,_, we_PRP created_VBD the_DT reciprocal_JJ 
          pop_NN 2_CD -_: 13_CD myc_NN Δpop_NN 1_CD strain_NN containing_VBG
          epitope-tagged_JJ endogenous_JJ Pop_NNP 2_CD p_NN in_IN a_DT 
          pop_NN 1_CD deletion_NN background_NN ._. The_DT
          distinct_JJ localization_NN patterns_NNS of_IN Pop_NNP 1_CD p-_NN 13_CD Myc_NNP and_CC
          Pop_NNP 2_CD p-_NN 13_CD Myc_NNP were_VBD fully_RB maintained_VBN in_IN these_DT strains_NNS (_( Fig_NNP ._.
          3_LS E_NNP )_) ._. This_DT observation_NN was_VBD confirmed_VBN by_IN overexpressing_VBG
          GFP-tagged_NNP Pop_NNP 1_CD p_NN or_CC Pop_NNP 2_CD p_NN in_IN 
          pop_NN 1_CD pop_NN 2_CD double_JJ deletion_NN mutants_NNS
          (_( data_NNS not_RB shown_VBN )_) ._. These_DT data_NNS indicate_VBP that_IN Pop_NNP 1_CD p_NN and_CC
          Pop_NNP 2_CD p_NN assume_VB their_PRP$ subcellular_NN localization_NN pattern_NN
          independent_JJ of_IN each_DT other_JJ ,_, indicating_VBG the_DT possibility_NN of_IN
          distinct_JJ nuclear_JJ and_CC cytoplasmic_JJ homooligomeric_JJ SCF_NNP
          Pop_NNP 1_CD pand_NN SCF_NNP Pop_NNP 2_CD pcomplexes_NNS ._.
        
        
          Differential_NNP F-_NNP box_NN requirements_NNS of_IN Pop_NNP 1_CD p_NN and_CC
          Pop_NNP 2_CD p_NN
          As_IN shown_VBN above_IN and_CC in_IN previous_JJ genetic_JJ work_NN [_NN 18_CD 20_CD ]_NN
          ,_, SCF_NNP Pop_NNP 1_CD p-_NN Pop_NNP 2_CD p-dependent_JJ Rum_NNP 1_CD p_NN degradation_NN requires_VBZ
          two_CD different_JJ proteins_NNS with_IN highly_RB conserved_JJ F-_NNP boxes_NNS
          (_( Fig_NNP ._. 4_LS A_DT )_) ._. To_TO better_JJR understand_VB the_DT apparent_JJ dual_JJ F-_NNP box_NN
          requirement_NN for_IN SCF_NNP Pop_NNP 1_CD p-_NN Pop_NNP 2_CD pfunction_NN ,_, we_PRP generated_VBD
          mutants_NNS of_IN Pop_NNP 1_CD p_NN and_CC Pop_NNP 2_CD p_NN lacking_VBG F-_NNP boxes_NNS (_( Pop_NNP 1_CD p-_NN ΔF_NN ,_,
          Pop_NNP 2_CD p-_NN ΔF_NN ;_: Fig_NNP ._. 4_LS B_NNP )_) ._. In_IN addition_NN ,_, we_PRP prepared_VBD a_DT set_NN of_IN
          mutants_NNS ,_, in_IN which_WDT the_DT F-_NNP boxes_NNS of_IN Pop_NNP 1_CD p_NN and_CC Pop_NNP 2_CD p_NN were_VBD
          swapped_VBN (_( Pop_NNP 1_CD p-_NN 2_CD F_NN ,_, Pop_NNP 2_CD p-_NN 1_CD F_NN ;_: Fig_NNP ._. 4_LS B_NNP )_) ._. The_DT mutants_NNS were_VBD
          tested_VBN for_IN their_PRP$ ability_NN to_TO suppress_VB polyploidy_NN and_CC Rum_NNP 1_CD p_NN
          accumulation_NN in_IN the_DT respective_JJ 
          pop_NN mutant_JJ strains_NNS ._.
          As_IN described_VBD previously_RB [_NN 20_CD ]_NN ,_, wild-type_JJ Pop_NNP 1_CD p_NN
          mildly_RB overexpressed_JJ from_IN a_DT pRep_NN 81_CD plasmid_NN fully_RB
          complemented_JJ the_DT polyploidization_NN phenotype_NN of_IN 
          pop_NN 1_CD mutants_NNS as_IN determined_VBN by_IN flow_NN
          cytometric_JJ measurement_NN of_IN the_DT cellular_JJ DNA_NNP content_NN (_( Fig_NNP
          4_CD C_NNP )_) ._. In_IN addition_NN ,_, Rum_NNP 1_CD p_NN accumulation_NN in_IN 
          pop_NN 1_CD mutants_NNS was_VBD efficiently_RB
          reversed_VBN by_IN wild-type_JJ Pop_NNP 1_CD p_NN (_( Fig_NNP ._. 4_LS D_NNP )_) ._. In_IN contrast_NN ,_, Pop_NNP 1_CD p_NN
          lacking_VBG its_PRP$ F-_NNP box_NN (_( Pop_NNP 1_CD p-_NN ΔF_NN )_) or_CC Pop_NNP 1_CD p_NN ,_, in_IN which_WDT the_DT F-_NNP box_NN
          was_VBD replaced_VBN by_IN the_DT F-_NNP box_NN of_IN Pop_NNP 2_CD p_NN (_( Pop_NNP 1_CD p-_NN 2_CD F_NN )_) were_VBD
          largely_RB inactive_JJ in_IN both_DT assays_NNS (_( Fig_NNP ._. 4_LS C_NNP ,_, 4_CD D_NNP )_) ._. Thus_RB ,_, as_IN
          with_IN many_JJ other_JJ F-_NNP box_NN proteins_NNS ,_, the_DT F-_NNP box_NN of_IN Pop_NNP 1_CD p_NN is_VBZ
          essential_JJ for_IN its_PRP$ 
          in_IN vivo_NN functions_NNS ._.
          In_IN contrast_NN ,_, wild-type_JJ Pop_NNP 2_CD p_NN ,_, the_DT corresponding_JJ F-_NNP box_NN
          mutant_JJ ,_, and_CC Pop_NNP 2_CD p_NN containing_VBG the_DT Pop_NNP 1_CD p_NN F-_NNP box_NN were_VBD equally_RB
          effective_JJ in_IN preventing_VBG Rum_NNP 1_CD p_NN accumulation_NN (_( Fig_NNP ._. 4_LS D_NNP )_) ._. The_DT
          same_JJ wild-type_JJ and_CC mutant_JJ proteins_NNS also_RB reversed_VBD the_DT mild_JJ
          polyploidy_NN phenotype_NN of_IN 
          pop_NN 2_CD disruptants_NNS (_( Fig_NNP ._. 4_LS C_NNP )_) ._. Thus_RB ,_,
          in_IN contrast_NN to_TO Pop_NNP 1_CD p_NN ,_, Pop_NNP 2_CD p_NN does_VBZ not_RB seem_VB ,_, to_TO require_VB its_PRP$
          F-_NNP box_NN to_TO mediate_VB Rum_NNP 1_CD p_NN degradation_NN 
          in_IN vivo_NN ._.
          To_TO further_VB substantiate_VB this_DT conclusion_NN ,_, we_PRP examined_VBD
          Rum_NNP 1_CD p_NN protein_NN stability_NN in_IN wild-type_JJ and_CC 
          pop_VB mutant_JJ strains_NNS expressing_VBG
          F-_NNP box-deleted_JJ Pop_NNP proteins_NNS from_IN the_DT weak_JJ pRep_NN 81_CD promoter_NN ._.
          Since_IN the_DT sensitivity_NN of_IN our_PRP$ Rum_NNP 1_CD p_NN sera_NN was_VBD insufficient_JJ
          to_TO detect_VB the_DT low_JJ levels_NNS present_JJ in_IN wild-type_JJ cells_NNS (_( see_VB
          Fig_NNP ._. 4_LS D_NNP ,_, lane_NN 9_CD )_) ,_, these_DT experiments_NNS were_VBD conducted_VBN in_IN a_DT
          background_NN where_WRB endogenous_JJ Rum_NNP 1_CD p_NN was_VBD modified_VBN with_IN 13_CD
          C-_NNP terminal_NN c-_NN Myc_NNP epitope_NN tags_NNS ._. Rum_NNP 1_CD p_NN half-life_NN was_VBD
          increased_VBN from_IN ~_NN 20_CD minutes_NNS in_IN wild-type_JJ to_TO greater_JJR than_IN
          100_CD minutes_NNS in_IN 
          pop_NN 1_CD or_CC 
          pop_NN 2_CD mutants_NNS (_( Fig_NNP ._. 5_LS )_) ._. While_IN F-_NNP box_NN
          deleted_VBN Pop_NNP 2_CD p_NN expressed_VBD from_IN plasmids_NNS reduced_VBD Rum_NNP 1_CD p_NN
          half-life_NN to_TO ~_NN 20_CD minutes_NNS in_IN 
          pop_NN 2_CD mutants_NNS ,_, F-_NNP box-deleted_JJ Pop_NNP 1_CD p_NN
          was_VBD completely_RB defective_JJ in_IN rescuing_VBG the_DT Rum_NNP 1_CD p_NN
          proteolysis_NNS defect_NN of_IN 
          pop_NN 1_CD mutants_NNS (_( Fig_NNP ._. 5_LS )_) ._. Instead_RB ,_,
          expression_NN of_IN Pop_NNP 1_CD p-_NN ΔF_NN in_IN 
          pop_NN 1_CD mutants_NNS led_VBN to_TO even_RB greater_JJR
          stabilization_NN of_IN Rum_NNP 1_CD p_NN ,_, potentially_RB due_JJ to_TO dominant_JJ
          negative_JJ interference_NN with_IN the_DT residual_JJ activity_NN of_IN Pop_NNP 2_CD p_NN
          and_CC /_NN or_CC other_JJ F-_NNP box_NN proteins_NNS ._.
        
        
          F-_NNP box_NN independent_JJ interaction_NN of_IN Pop_NNP 1_CD p_NN and_CC
          Pop_NNP 2_CD p_NN
          The_DT failure_NN of_IN the_DT Pop_NNP 2_CD p_NN F-_NNP box_NN to_TO replace_VB the_DT F-_NNP box_NN of_IN
          Pop_NNP 1_CD p_NN as_RB well_RB as_IN the_DT finding_VBG that_IN it_PRP is_VBZ not_RB essential_JJ for_IN
          Rum_NNP 1_CD p_NN degradation_NN could_MD be_VB explained_VBN ,_, if_IN it_PRP was_VBD not_RB
          critically_RB involved_VBN in_IN SCF_NNP Pop_NNP 1_CD p-_NN Pop_NNP 2_CD pprotein_NN
          interactions_NNS ._. We_PRP therefore_RB tested_VBD the_DT possibility_NN that_IN
          Pop_NNP 2_CD p_NN can_MD be_VB tethered_VBN to_TO the_DT SCF_NNP core_NN complex_JJ
          independently_RB of_IN its_PRP$ F-_NNP box_NN via_IN an_DT interaction_NN with_IN Pop_NNP 1_CD p_NN ._.
          Consistent_NNP with_IN this_DT hypothesis_NNS ,_, co-immunoprecipitation_JJ
          experiments_NNS of_IN overexpressed_JJ proteins_NNS revealed_VBD that_IN the_DT
          Pop_NNP 1_CD p-_NN Pop_NNP 2_CD p_NN interaction_NN occurs_VBZ independently_RB of_IN the_DT
          F-_NNP boxes_NNS of_IN both_DT Pop_NNP 1_CD p_NN and_CC Pop_NNP 2_CD p_NN (_( Fig_NNP ._. 6_CD A_DT )_) ._.
          We_PRP had_VBD previously_RB mapped_VBN the_DT domain_NN of_IN Pop_NNP 2_CD p_NN that_IN
          interacts_NNS with_IN Pop_NNP 1_CD p_NN to_TO an_DT N-_NNP terminal_NN fragment_NN consisting_VBG
          of_IN the_DT first_JJ 241_CD amino_JJ acids_NNS and_CC lacking_VBG the_DT F-_NNP box_NN (_( [_NN 20_CD
          ]_NN ,_, Fig_NNP ._. 6_CD B_NNP ,_, lane_NN 8_CD )_) ._. In_IN co-immunoprecipitation_JJ
          experiments_NNS with_IN overexpressed_JJ proteins_NNS ,_, this_DT fragment_NN
          also_RB bound_VBN to_TO an_DT N-_NNP terminal_NN piece_NN containing_VBG the_DT first_JJ
          402_CD residues_NNS of_IN Pop_NNP 1_CD p_NN (_( Fig_NNP ._. 6_CD B_NNP ,_, lane_NN 12_CD )_) ._. Thus_RB ,_, the_DT
          Pop_NNP 1_CD p-_NN Pop_NNP 2_CD p_NN interaction_NN is_VBZ mediated_JJ by_IN their_PRP$ N-_NNP terminal_NN
          domains_NNS ._. A_DT further_JJ truncation_NN mutant_JJ mapped_VBN the_DT Pop_NNP 2_CD p_NN
          binding_JJ domain_NN to_TO a_DT region_NN between_IN residues_NNS 228_CD and_CC 402_CD
          of_IN Pop_NNP 1_CD p_NN (_( Fig_NNP ._. 6_CD B_NNP ,_, lanes_NNS 9_CD ,_, 10_CD )_) ._.
        
        
          Individual_NNP SCF_NNP Pop_NNP 1_CD pand_NN SCF_NNP Pop_NNP 2_CD pcomplexes_NNS bearing_NN
          ubiquitin_NN ligase_NN activity_NN
          The_DT apparent_JJ dispensibility_NN of_IN the_DT F-_NNP box_NN of_IN Pop_NNP 2_CD p_NN for_IN
          Rum_NNP 1_CD p_NN degradation_NN and_CC binding_JJ to_TO Pop_NNP 1_CD p_NN raised_VBD the_DT
          question_NN of_IN why_WRB Pop_NNP 2_CD p_NN does_VBZ contain_VB an_DT F-_NNP box_NN ._. Based_VBN on_IN the_DT
          subcellular_NN localization_NN data_NNS ,_, we_PRP considered_VBD the_DT
          possibility_NN that_IN the_DT F-_NNP box_NN of_IN Pop_NNP 2_CD p_NN may_MD mediate_VB the_DT
          assembly_NN of_IN a_DT cytoplasmically_RB localized_JJ SCF_NNP Pop_NNP 2_CD pcomplex_NN ,_,
          independent_JJ of_IN Pop_NNP 1_CD p_NN ._. To_TO demonstrate_VB this_DT ,_, we_PRP again_RB used_VBD
          the_DT strain_NN in_IN which_WDT endogenous_JJ Pop_NNP 2_CD p_NN was_VBD modified_VBN by_IN 13_CD
          Myc_NNP epitope_NN tags_NNS in_IN a_DT 
          pop_NN 1_CD deletion_NN background_NN ._. The_DT same_JJ
          experiments_NNS were_VBD carried_VBN out_IN with_IN the_DT reverse_NN stain_VB ,_,
          which_WDT contained_VBD Pop_NNP 1_CD p-_NN 13_CD Myc_NNP in_IN a_DT 
          pop_NN 2_CD background_NN ._. As_IN a_DT reference_NN for_IN
          SCF_NNP Popcomplex_NNP formation_NN ,_, we_PRP used_VBD strains_NNS carrying_VBG 13_CD Myc_NNP
          epitope-tagged_JJ Pop_NNP 1_CD p_NN or_CC Pop_NNP 2_CD p_NN integrated_VBN into_IN the_DT genome_NN
          of_IN wild-type_JJ cells_NNS ._.
          Pip_NNP 1_CD p_NN immunoprecipitates_NNS were_VBD prepared_VBN from_IN lysates_NNS of_IN
          these_DT four_CD strains_NNS and_CC appropriate_JJ controls_NNS ,_, and_CC
          co-purification_JJ of_IN SCF_NNP components_NNS was_VBD determined_VBN by_IN
          immunoblotting_VBG ._. These_DT experiments_NNS showed_VBD that_IN both_DT F-_NNP box_NN
          proteins_NNS ,_, in_IN the_DT absence_NN of_IN their_PRP$ respective_JJ
          heterooligomerization_NN partner_NN ,_, could_MD individually_RB bind_NN to_TO
          Pip_NNP 1_CD p_NN in_IN complexes_NNS that_WDT also_RB contained_VBD Psh_NNP 1_CD p_NN and_CC Pcu_NNP 1_CD p_NN
          (_( Fig_NNP ._. 7_CD A_DT )_) ._. These_DT findings_NNS indicate_VBP the_DT existence_NN of_IN
          distinct_JJ SCF_NNP Pop_NNP 1_CD pand_NN SCF_NNP Pop_NNP 2_CD pcomplexes_NNS 
          in_IN vivo_NN ._.
          To_TO further_VB substantiate_VB this_DT conclusion_NN ,_, we_PRP used_VBD gel_NN
          filtration_NN to_TO compare_VB the_DT elution_NN profiles_NNS of_IN Pop_NNP 1_CD p_NN and_CC
          Pop_NNP 2_CD p_NN in_IN the_DT presence_NN or_CC absence_NN of_IN their_PRP$ respective_JJ
          dimerization_NN partners_NNS ._. If_IN recruitment_NN of_IN Pop_NNP 2_CD p_NN into_IN a_DT
          high_JJ molecular_JJ weight_NN SCF_NNP complex_JJ required_VBD
          heterooligomerization_NN with_IN Pop_NNP 1_CD p_NN ,_, its_PRP$ elution_NN profile_NN
          would_MD be_VB expected_VBN to_TO shift_VB to_TO a_DT smaller_JJR size_NN in_IN the_DT
          absence_NN of_IN Pop_NNP 1_CD p_NN ._. Consistent_NNP with_IN the_DT results_NNS presented_VBN
          in_IN Fig_NNP ._. 1_LS C_NNP ,_, Pop_NNP 2_CD p_NN ,_, together_RB with_IN SCF_NNP core_NN subunits_NNS ,_,
          eluted_JJ in_IN fractions_NNS corresponding_JJ to_TO 400_CD -_: 600_CD kDa_NN ,_,
          irrespective_RB of_IN whether_IN Pop_NNP 1_CD p_NN was_VBD present_JJ or_CC not_RB (_( Fig_NNP ._.
          7_CD B_NNP )_) ._. In_IN the_DT reverse_JJ experiment_NN ,_, the_DT elution_NN profile_NN of_IN
          Pop_NNP 1_CD p_NN was_VBD found_VBN to_TO be_VB independent_JJ of_IN the_DT presence_NN of_IN
          Pop_NNP 2_CD p_NN (_( Fig_NNP ._. 7_CD B_NNP )_) ._.
          While_IN these_DT data_NNS support_VBP the_DT existence_NN of_IN distinct_JJ SCF_NNP
          Pop_NNP 1_CD pand_NN SCF_NNP Pop_NNP 2_CD pcomplexes_NNS ,_, individual_JJ binding_JJ of_IN Pop_NNP 1_CD p_NN
          and_CC Pop_NNP 2_CD p_NN to_TO SCF_NNP core_NN components_NNS in_IN the_DT absence_NN of_IN their_PRP$
          heterodimerizing_VBG F-_NNP box_NN protein_NN partners_NNS does_VBZ not_RB rule_VB out_RP
          the_DT possibility_NN that_IN these_DT complexes_NNS represent_VBP inactive_JJ
          intermediates_NNS formed_VBN during_IN the_DT normal_JJ assembly_NN of_IN
          functional_JJ SCF_NNP Pop_NNP 1_CD p-_NN Pop_NNP 2_CD pcomplexes_NNS ._. To_TO exclude_VB this_DT
          possibility_NN ,_, we_PRP asked_VBD whether_IN distinct_JJ SCF_NNP Pop_NNP 1_CD pand_NN SCF_NNP
          Pop_NNP 2_CD pcomplexes_NNS bear_VBP ubiquitin_NN ligase_NN activity_NN 
          in_IN vitro_NN ._. To_TO this_DT end_NN ,_, we_PRP
          performed_VBD 
          in_IN vitro_NN ubiquitylation_NN assays_NNS ._.
          Since_IN the_DT substrates_NNS of_IN putative_JJ SCF_NNP Pop_NNP 1_CD pand_NN SCF_NNP
          Pop_NNP 2_CD pubiquitin_NN ligases_NNS are_VBP unknown_JJ ,_, we_PRP adopted_VBD a_DT
          substrate-independent_JJ assay_NN originally_RB described_VBN by_IN
          Lyapina_NNP 
          et_CC al_NN ._. [_NN 27_CD ]_NN ._. For_IN this_DT
          experiment_NN ,_, we_PRP again_RB used_VBD the_DT strains_NNS harboring_VBG
          genomically_RB integrated_VBN Myc_NNP epitope-tagged_JJ Pop_NNP 1_CD p_NN or_CC Pop_NNP 2_CD p_NN
          in_IN a_DT background_NN deficient_NN in_IN the_DT respective_JJ
          heterooligomerization_NN partner_NN (_( 
          Δpop_NN 2_CD pop_NN 1_CD -_: 13_CD myc_NN ,_, 
          Δpop_NN 1_CD pop_NN 2_CD -_: 13_CD myc_NN strains_NNS )_) ._. Pop_NNP 1_CD p_NN
          and_CC Pop_NNP 2_CD p_NN complexes_NNS were_VBD immunopurified_JJ with_IN Myc_NNP
          antibodies_NNS and_CC employed_VBN in_IN 
          in_IN vitro_NN ubiquitylation_NN assays_NNS upon_IN
          addition_NN of_IN E_NNP 1_CD ,_, UBC_NNP 3_CD ,_, ubiquitin_NN ,_, and_CC ATP_NNP ._. High_NNP molecular_JJ
          weight_NN products_NNS generated_VBN in_IN the_DT reaction_NN were_VBD detected_VBN
          by_IN immunoblotting_VBG with_IN ubiquitin_NN antibodies_NNS ._. As_IN
          references_NNS ,_, we_PRP used_VBD strains_NNS expressing_VBG Myc-tagged_NNP Pop_NNP 1_CD p_NN
          or_CC Pop_NNP 2_CD p_NN in_IN a_DT wild-type_JJ background_NN ._. The_DT experiment_NN
          demonstrated_VBN that_IN Pop_NNP 1_CD p_NN and_CC Pop_NNP 2_CD p_NN each_DT associate_NN with_IN
          polyubiquitylation_NN activity_NN even_RB in_IN the_DT absence_NN of_IN their_PRP$
          respective_JJ heterooligomerizing_VBG F-_NNP box_NN proteins_NNS (_( Fig_NNP ._. 7_CD C_NNP )_) ._.
          Thus_RB Pop_NNP 1_CD p_NN and_CC Pop_NNP 2_CD p_NN appear_VBP to_TO assemble_VB into_IN distinct_JJ SCF_NNP
          complexes_NNS bearing_NN ubiquitin_NN ligase_NN activity_NN 
          in_IN vitro_NN ._.
        
      
      
        Discussion_NNP
        
          Molecular_NNP architecture_NN of_IN SCF_NNP Popcomplexes_NNP
          The_DT phenomenon_NN of_IN F-_NNP box_NN protein_NN oligomerization_NN is_VBZ not_RB
          unique_JJ to_TO SCF_NNP Pop_NNP ._. Although_IN the_DT crystal_NN structure_NN of_IN the_DT
          SKP_NNP 1_CD -_: SKP_NNP 2_CD complex_JJ ,_, derived_VBN from_IN bacterially_RB expressed_VBD
          proteins_NNS ,_, revealed_VBD a_DT single_JJ SKP_NNP 2_CD monomer_NN bound_VBN to_TO SKP_NNP 1_CD [_NN
          28_CD ]_NN ,_, biochemical_JJ studies_NNS showed_VBD that_IN budding_VBG yeast_NN
          Cdc_NNP 4_CD p_NN ,_, a_DT close_JJ homologue_NN of_IN Pop_NNP 1_CD p_NN \_NN Pop_NNP 2_CD p_NN ,_, forms_NNS
          homooligomers_NNS when_WRB expressed_VBD in_IN insect_NN cells_NNS (_( Correll_NNP and_CC
          Deshaies_NNP ,_, personal_JJ communication_NN )_) ._. Similarly_RB ,_, β-_NN TRCP_NNP 1_CD and_CC
          2_CD ,_, which_WDT target_VBP IκBα_NNP for_IN degradation_NN as_IN homooligomers_NNS ,_,
          form_NN heterooligomers_NNS that_IN each_DT bind_NN SCF_NNP core_NN subunits_NNS ,_,
          although_IN no_DT biochemical_JJ activity_NN for_IN this_DT
          heterooligomeric_JJ complex_NN was_VBD demonstrated_VBN [_NN 29_CD ]_NN ._.
          Finally_RB ,_, Pop_NNP 1_CD p_NN and_CC Pop_NNP 2_CD p_NN homooligomerize_NN ,_, at_IN least_JJS when_WRB
          overexpressed_JJ [_NN 18_CD ]_NN ,_, indicating_VBG that_IN both_DT F-_NNP box_NN
          proteins_NNS may_MD also_RB be_VB present_JJ as_IN homooligomers_NNS in_IN
          individual_JJ SCF_NNP Pop_NNP 1_CD pand_NN SCF_NNP Pop_NNP 2_CD p_NN ,_, respectively_RB ._.
          A_DT surprising_JJ finding_NN of_IN this_DT study_NN was_VBD that_IN the_DT F-_NNP box_NN
          of_IN Pop_NNP 2_CD p_NN is_VBZ dispensable_JJ for_IN Rum_NNP 1_CD p_NN degradation_NN and_CC ploidy_NN
          control_NN ,_, while_IN the_DT F-_NNP box_NN of_IN Pop_NNP 1_CD p_NN is_VBZ essential_JJ for_IN both_DT
          functions_NNS (_( Fig_NNP ._. 4_LS Dand_NNP 5_LS )_) ._. The_DT Pop_NNP 2_CD p_NN F-_NNP box_NN is_VBZ unlikely_JJ to_TO
          be_VB a_DT degenerate_VB ,_, non-functional_JJ ,_, and_CC hence_RB dispensable_JJ ,_,
          motif_NN ,_, as_IN it_PRP carries_VBZ all_DT signature_NN residues_NNS of_IN the_DT F-_NNP box_NN
          (_( Fig_NNP ._. 4_LS A_DT )_) ._. In_IN addition_NN ,_, Pop_NNP 2_CD p_NN ,_, in_IN the_DT absence_NN of_IN Pop_NNP 1_CD p_NN ,_,
          assembles_NNS into_IN a_DT complex_JJ containing_VBG all_DT SCF_NNP core_NN subunits_NNS
          identified_VBN here_RB (_( Fig_NNP ._. 7_CD A_DT )_) ._. At_IN present_JJ ,_, we_PRP cannot_NN exclude_VB
          that_IN residues_NNS outside_IN the_DT F-_NNP box_NN mediate_VB binding_JJ of_IN F-_NNP box_NN
          deleted_VBN Pop_NNP 2_CD p_NN to_TO Psh_NNP 1_CD p_NN and_CC other_JJ core_NN subunits_NNS ._.
          Consistent_NNP with_IN this_DT idea_NN ,_, biochemical_JJ studies_NNS based_VBN on_IN
          the_DT crystal_NN structure_NN of_IN the_DT human_JJ SKP_NNP 1_CD -_: SKP_NNP 2_CD complex_NN
          revealed_VBD cooperation_NN of_IN the_DT SKP_NNP 2_CD F-_NNP box_NN with_IN an_DT adjacent_JJ
          region_NN in_IN binding_JJ of_IN SKP_NNP 1_CD [_NN 28_CD ]_NN ._. Consistent_NNP with_IN this_DT
          finding_NN ,_, certain_JJ truncation_NN mutants_NNS of_IN the_DT budding_VBG yeast_NN
          F-_NNP box_NN proteins_NNS Grr_NNP 1_CD p_NN and_CC Cdc_NNP 4_CD p_NN interact_NN poorly_RB with_IN
          Skp_NNP 1_CD p_NN ,_, despite_IN the_DT retainment_NN of_IN their_PRP$ F-_NNP boxes_NNS [_NN 30_CD 31_CD ]_NN
          ._. On_IN the_DT other_JJ hand_NN ,_, the_DT F-_NNP box_NN of_IN Pop_NNP 1_CD p_NN is_VBZ essential_JJ for_IN
          Rum_NNP 1_CD p_NN degradation_NN (_( Fig_NNP ._. 5_LS )_) ,_, arguing_VBG that_IN residues_NNS outside_IN
          the_DT F-_NNP box_NN are_VBP insufficient_JJ to_TO mediate_VB recruitment_NN of_IN Pop_NNP
          proteins_NNS into_IN SCF_NNP complexes_NNS ._.
          Based_VBN on_IN the_DT non-essential_JJ function_NN of_IN the_DT Pop_NNP 2_CD p_NN
          F-_NNP box_NN ,_, we_PRP propose_VBP a_DT molecular_JJ architecture_NN of_IN SCF_NNP
          Pop_NNP 1_CD p-_NN Pop_NNP 2_CD p_NN ,_, in_IN which_WDT Pop_NNP 2_CD p_NN is_VBZ tethered_VBN to_TO the_DT core_NN
          subunits_NNS through_IN interaction_NN with_IN Pop_NNP 1_CD p_NN ._. Although_IN we_PRP have_VBP
          no_DT direct_JJ biochemical_JJ evidence_NN to_TO confirm_VB this_DT
          proposition_NN ,_, which_WDT would_MD require_VB Pop_NNP 2_CD p_NN point_NN mutants_NNS
          deficient_NN in_IN Pop_NNP 1_CD p_NN binding_JJ ,_, our_PRP$ data_NNS show_VBP that_IN severely_RB
          truncated_JJ N-_NNP terminal_NN fragments_NNS of_IN Pop_NNP 1_CD p_NN and_CC Pop_NNP 2_CD p_NN lacking_VBG
          both_DT F-_NNP boxes_NNS and_CC WD_NNP repeat_NN domains_NNS are_VBP sufficient_JJ to_TO
          mediate_VB their_PRP$ interaction_NN (_( Fig_NNP ._. 6_CD B_NNP )_) ._. Similarly_RB ,_,
          dimerization_NN of_IN β-_NN TRCP_NNP proteins_NNS is_VBZ mediated_JJ by_IN N-_NNP terminal_NN
          "_'' D-_NNP domains_NNS "_'' lacking_VBG binding_JJ of_IN SKP_NNP 1_CD and_CC other_JJ SCF_NNP core_NN
          subunits_NNS [_NN 29_CD ]_NN ._. According_VBG to_TO our_PRP$ model_NN ,_, the_DT F-_NNP box_NN of_IN
          Pop_NNP 2_CD p_NN would_MD be_VB essential_JJ only_RB for_IN the_DT Pop_NNP 1_CD p-independent_JJ
          activities_NNS of_IN Pop_NNP 2_CD p_NN ,_, for_IN which_WDT we_PRP provide_VBP tentative_JJ
          evidence_NN by_IN demonstrating_VBG the_DT 
          in_IN vivo_NN assembly_NN of_IN SCF_NNP
          Pop_NNP 2_CD pcomplexes_NNS (_( Fig_NNP ._. 7_CD A_DT )_) ._. These_DT complexes_NNS bear_VBP ubiquitin_NN
          ligase_NN activity_NN in_IN a_DT substrate-independent_JJ 
          in_IN vitro_NN assay_NN (_( Fig_NNP ._. 7_CD C_NNP )_) ._. To_TO what_WP
          extent_NN this_DT assay_NN reflects_VBZ the_DT 
          in_IN vivo_NN activity_NN of_IN SCF_NNP Pop_NNP 2_CD pwill_NN
          become_VB testable_JJ ,_, once_RB the_DT putative_JJ substrates_NNS of_IN SCF_NNP
          Pop_NNP 2_CD pare_VB identified_VBN ._.
        
        
          Subcellular_NNP compartmentalization_NN of_IN SCF_NNP Popas_NNP a_DT
          potential_JJ mechanism_NN for_IN substrate_NN selection_NN
          Another_DT surprising_JJ observation_NN of_IN this_DT study_NN was_VBD that_IN
          Pop_NNP 1_CD p_NN is_VBZ primarily_RB localized_VBN to_TO the_DT nucleus_NN ,_, whereas_IN
          Pop_NNP 2_CD p_NN is_VBZ present_JJ in_IN both_DT the_DT cytoplasm_NN and_CC the_DT nucleus_NN
          (_( Fig_NNP ._. 3_LS )_) ._. While_IN ,_, nuclear_JJ localization_NN was_VBD expected_VBN ,_, since_IN
          both_DT known_VBN substrates_NNS of_IN SCF_NNP Pop_NNP 1_CD p-_NN Pop_NNP 2_CD p_NN ,_, Cdc_NNP 18_CD p_NN and_CC
          Rum_NNP 1_CD p_NN ,_, are_VBP primarily_RB nuclear_JJ proteins_NNS ,_, the_DT cytoplasmic_JJ
          localization_NN of_IN Pop_NNP 2_CD p_NN suggests_VBZ an_DT activity_NN of_IN SCF_NNP
          Pop_NNP 2_CD pdirected_JJ toward_IN unknown_JJ cytoplasmic_JJ substrates_NNS ._. In_IN
          support_NN of_IN this_DT notion_NN ,_, as_IN with_IN human_JJ SCF_NNP subunits_NNS [_NN 32_CD ]_NN
          ,_, fission_NN yeast_NN SCF_NNP core_NN subunits_NNS are_VBP also_RB present_JJ in_IN the_DT
          cytoplasm_NN ,_, as_IN shown_VBN here_RB for_IN overexpressed_JJ GFP-fusions_NNP
          (_( Fig_NNP ._. 3_LS A_DT )_) ,_, and_CC for_IN endogenous_JJ Pcu_NNP 1_CD p_NN by_IN immunostaining_VBG in_IN
          a_DT previous_JJ report_NN [_NN 24_CD ]_NN ._.
          By_IN analogy_NN ,_, additional_JJ nuclear_JJ substrates_NNS of_IN SCF_NNP
          Pop_NNP 1_CD pmay_NN exist_VB ._. For_IN example_NN ,_, Pop_NNP 1_CD p_NN is_VBZ involved_VBN in_IN the_DT
          control_NN of_IN the_DT RNA_NNP levels_NNS of_IN the_DT cyclin_NN Cig_NNP 2_CD p_NN [_NN 33_CD ]_NN ._.
          While_IN it_PRP is_VBZ unclear_JJ whether_IN this_DT effect_NN is_VBZ mediated_JJ at_IN
          the_DT level_NN of_IN transcription_NN or_CC mRNA_NN stability_NN ,_, the_DT budding_VBG
          yeast_NN F-_NNP box_NN protein_NN Met_NNP 30_CD p_NN was_VBD recently_RB shown_VBN to_TO regulate_VB
          the_DT ubiquitylation_NN and_CC activity_NN ,_, but_CC not_RB degradation_NN ,_, of_IN
          the_DT transcription_NN factor_NN Met_NNP 4_CD p_NN [_NN 34_CD ]_NN ._. In_IN addition_NN ,_, 
          pop_NN 1_CD mutants_NNS display_VBP an_DT increased_VBN
          rate_NN of_IN chromosome_NN loss_NN ,_, a_DT phenotype_NN that_WDT is_VBZ not_RB easily_RB
          explained_VBN by_IN accumulation_NN of_IN Rum_NNP 1_CD p_NN and_CC Cdc_NNP 18_CD p_NN [_NN 23_CD ]_NN ._.
          Finally_RB ,_, 
          pop_NN 1_CD mutants_NNS are_VBP sensitive_JJ to_TO UV_NNP
          irradiation_NN ,_, whereas_IN 
          pop_NN 2_CD mutants_NNS are_VBP not_RB (_( D_NNP ._. Griffiths_NNP
          and_CC D_NNP ._. A_DT ._. W_NNP ._. ,_, unpublished_JJ observation_NN )_) ._. It_PRP is_VBZ therefore_RB
          likely_JJ that_IN other_JJ substrates_NNS of_IN Pop_NNP 1_CD p_NN and_CC Pop_NNP 2_CD p_NN ,_, in_IN
          addition_NN to_TO their_PRP$ common_JJ substrates_NNS Cdc_NNP 18_CD p_NN and_CC Rum_NNP 1_CD p_NN ,_, do_VBP
          exist_VB ._.
          The_DT idea_NN developed_VBN above_IN that_DT F-_NNP box_NN protein_NN
          compartmentalization_NN contributes_VBZ to_TO substrate_NN selection_NN
          was_VBD recently_RB confirmed_VBN directly_RB for_IN Cdc_NNP 4_CD p-mediated_JJ
          degradation_NN of_IN Far_NNP 1_CD p_NN in_IN budding_VBG yeast_NN [_NN 35_CD ]_NN ._. Both_DT ,_,
          Cdc_NNP 4_CD p_NN and_CC Far_NNP 1_CD p_NN are_VBP nuclear_JJ proteins_NNS in_IN vegetative_JJ cells_NNS ,_,
          owing_VBG to_TO the_DT presence_NN of_IN nuclear_JJ localization_NN signals_NNS
          (_( NLS_NNP )_) ._. Fusion_NNP of_IN Cdc_NNP 4_CD p_NN with_IN a_DT nuclear_JJ export_NN signal_NN
          (_( NES-Cdc_NNP 4_CD p_NN )_) prevented_VBN its_PRP$ nuclear_JJ localization_NN and_CC its_PRP$
          ability_NN to_TO direct_VB the_DT degradation_NN of_IN nuclear_JJ Far_NNP 1_CD p_NN ._. When_WRB
          Far_NNP 1_CD p_NN also_RB was_VBD targeted_VBN to_TO the_DT cytoplasm_NN by_IN disrupting_VBG
          its_PRP$ NLS_NNP ,_, NES-Cdc_NNP 4_CD p_NN degraded_JJ ΔNLS-Far_JJ 1_CD p_NN in_IN the_DT cytoplasm_NN [_NN
          35_CD ]_NN ._.
          A_DT putative_JJ NLS_NNP is_VBZ also_RB present_JJ in_IN the_DT N-_NNP terminus_JJ of_IN
          Pop_NNP 1_CD p_NN located_VBN between_IN the_DT F-_NNP box_NN and_CC the_DT WD-repeat_NNP domain_NN
          (_( 393_CD PEKIKRC_NNP )_) ._. An_DT N-_NNP terminal_NN Pop_NNP 1_CD p_NN fragment_NN containing_VBG
          this_DT motif_NN ,_, when_WRB fused_JJ to_TO the_DT WD-repeat_NNP region_NN of_IN Pop_NNP 2_CD p_NN ,_,
          is_VBZ targeted_VBN exclusively_RB to_TO the_DT nucleus_NN (_( R_NN ._. L_NNP ._. &_CC
          D_NNP ._. A_DT ._. W_NNP ._. ,_, unpublished_JJ observation_NN )_) ._. Like_IN wild-type_JJ Pop_NNP 2_CD p_NN ,_,
          the_DT reverse_NN Pop_NNP 2_CD p-_NN N_NNP /_NN Pop_NNP 1_CD p-_NN C_NNP chimera_NN localizes_NNS to_TO both_DT the_DT
          nucleus_NN and_CC the_DT cytoplasm_NN ,_, again_RB indicating_VBG that_IN Pop_NNP 1_CD p_NN ,_,
          but_CC not_RB Pop_NNP 2_CD p_NN ,_, has_VBZ a_DT functional_JJ NLS_NNP in_IN its_PRP$ N-_NNP terminus_JJ
          (_( R_NN ._. L_NNP ._. &_CC D_NNP ._. A_DT ._. W_NNP ._. ,_, unpublished_JJ observation_NN )_) ._. It_PRP is_VBZ
          unclear_JJ ,_, at_IN present_JJ ,_, what_WP regulates_VBZ Pop_NNP 2_CD p_NN distribution_NN ._.
          One_CD possibility_NN is_VBZ that_IN Pop_NNP 2_CD p_NN is_VBZ co-imported_JJ in_IN a_DT complex_NN
          with_IN other_JJ SCF_NNP subunits_NNS that_WDT is_VBZ preformed_JJ in_IN the_DT
          cytoplasm_NN ._. Since_IN Pop_NNP 2_CD p_NN distribution_NN is_VBZ independent_JJ of_IN
          Pop_NNP 1_CD p_NN (_( Fig_NNP ._. 3_LS E_NNP )_) ,_, SCF_NNP core_NN subunits_NNS are_VBP the_DT most_RBS likely_JJ
          candidates_NNS for_IN such_JJ a_DT function_NN ._. In_IN line_NN with_IN this_DT
          suggestion_NN ,_, it_PRP was_VBD previously_RB demonstrated_VBN that_IN
          HRT_NNP 1_CD /_NN ROC_NNP 1_CD /_NN RBX_NNP 1_CD promotes_VBZ nuclear_JJ accumulation_NN of_IN CUL_NNP 1_CD [_NN 32_CD
          ]_NN ._.
        
      
      
        Conclusion_NNP
        Our_PRP$ data_NNS suggest_VBP homo-_NN and_CC heterooligomerization_NN of_IN the_DT
        F-_NNP box_NN proteins_NNS Pop_NNP 1_CD p_NN and_CC Pop_NNP 2_CD p_NN as_IN a_DT mechanism_NN for_IN
        generating_NN combinatorial_NN diversity_NN of_IN SCF_NNP function_NN in_IN
        fission_NN yeast_NN ._. A_DT heterooligomeric_JJ SCF_NNP Pop_NNP 1_CD p-_NN Pop_NNP 2_CD pcomplex_NN
        mediates_NNS polyubiquitylation_NN of_IN phosphorylated_JJ Rum_NNP 1_CD p_NN ._. In_IN
        addition_NN ,_, compartmentalization_NN of_IN homooligomeric_JJ SCF_NNP
        Pop_NNP 1_CD pand_NN SCF_NNP Pop_NNP 2_CD pcomplexes_NNS may_MD direct_VB the_DT ubiquitylation_NN
        of_IN unknown_JJ nuclear_JJ and_CC cytoplasmic_JJ substrates_NNS ._.
      
      
        Methods_NNP
        
          Plasmids_NNP and_CC yeast_NN strains_NNS
          
          S_NNP ._. pombe_NN genes_NNS for_IN 
          psh_NN 1_CD and_CC 
          pip_NN 1_CD were_VBD identified_VBN in_IN the_DT Sanger_NNP
          Centre_NNP 
          S_NNP ._. pombe_NN sequence_NN database_NN based_VBN on_IN
          their_PRP$ homology_NN to_TO the_DT respective_JJ human_JJ and_CC budding_VBG yeast_NN
          proteins_NNS ._. Complementary_NNP DNAs_NNP were_VBD amplified_VBN by_IN PCR_NNP ,_,
          subcloned_JJ into_IN pREp_NN 81_CD ._. 6_CD xHis-Myc_JJ ,_, pRep_NN 3_CD ._. 6_CD His-_NNP Myc_NNP ,_, or_CC
          pRep_NN 4_CD ._. HA_NNP ,_, and_CC sequenced_JJ ._. Deletion_NNP strains_NNS and_CC
          epitope-tagged_JJ stains_NNS were_VBD constructed_VBN by_IN one-step_JJ gene_NN
          replacement_NN using_VBG PCR-generated_NNP fragments_NNS containing_VBG
          kanamycin_NN or_CC 
          ura_NN 4_CD cassettes_NNS [_NN 36_CD ]_NN ._. Growth_NN
          media_NNS ,_, flow_NN cytometry_NN ,_, and_CC all_DT other_JJ relevant_JJ 
          S_NNP ._. pombe_NN techniques_NNS were_VBD described_VBN
          previously_RB [_NN 37_CD ]_NN ._.
          To_TO generate_VB the_DT 
          pop_NN 1_CD :_: :_: ura_NN 4_CD pop_NN 2_CD -_: 13_CD myc-kan_JJ strain_NN ,_,
          an_DT 
          h_NN +_NN 
          pop_NN 1_CD :_: :_: ura_NN 4_CD ura_NN 4_CD -_: d_SYM 18_CD leul-_NN 32_CD
          pRep_NN 81_CD ._. pop_NN 1_CD strain_NN was_VBD crossed_VBN with_IN a_DT 
          h_NN -_: 
          leul-_NN 32_CD ura_NN 4_CD -_: d_SYM 18_CD
          pop_NN 2_CD -_: 13_CD myc-kan_JJ strain_NN ,_, followed_VBN by_IN selection_NN of_IN
          spores_NNS on_IN G_NNP 418_CD /_NN ura_NN -_: EMM_NNP plates_NNS ._. The_DT pRep_NN 81_CD ._. 
          pop_NN 1_CD plasmid_NN required_VBN to_TO complement_VB
          the_DT sterility_NN of_IN the_DT 
          pop_NN 1_CD deletion_NN strain_NN was_VBD lost_VBN by_IN
          growth_NN in_IN non-selective_JJ media_NNS (_( YES_NNP )_) for_IN several_JJ
          generations_NNS ._. The_DT resulting_VBG strain_NN was_VBD verified_VBN by_IN PCR_NNP and_CC
          immunoblotting_VBG ._. The_DT 
          pop_NN 2_CD :_: :_: ura_NN 4_CD pop_NN 1_CD -_: 13_CD myc-kan_JJ strain_NN
          was_VBD generated_VBN in_IN an_DT analogous_JJ fashion_NN ._.
        
        
          Antibodies_NNP
          Rabbit_NNP antisera_NN were_VBD raised_VBN at_IN Josman_NNP LCC_NNP (_( Napa_NNP ,_, CA_NNP )_)
          against_IN bacterially_RB expressed_VBD MBP-Psh_NNP 1_CD p_NN ,_, GST-Pcu_NNP 1_CD p_NN ,_,
          GST-Pip_NNP 1_CD p_NN ,_, and_CC GST-Pop_NNP 1_CD p_NN ._. Sera_NNP were_VBD affinity_NN purified_JJ on_IN
          affinity_NN matrices_NNS containing_VBG immobilized_JJ GST-Psh_NNP 1_CD p_NN ,_,
          MBP-Pcu_NNP 1_CD p_NN ,_, MBP-Pip_NNP 1_CD p_NN ,_, and_CC MBP-Pop_NNP 1_CD p_NN ._. Column_NNP eluates_NNS were_VBD
          concentrated_VBN to_TO ~_NN 1_CD mg_NN /_NN ml_NN and_CC tittered_JJ by_IN immunoblotting_VBG ._.
          Rabbit_NNP antisera_NN against_IN Pop_NNP 2_CD p_NN and_CC Rum_NNP 1_CD p_NN were_VBD described_VBN
          before_IN [_NN 20_CD ]_NN ._. Monoclonal_NNP Myc_NNP and_CC HA_NNP antibodies_NNS were_VBD
          purified_JJ from_IN 9_CD E_NNP 10_CD and_CC 12_CD CA_NNP 5_CD tissue_NN culture_NN supernatants_NNS
          by_IN binding_JJ to_TO protein_NN A_DT ._.
        
        
          Immunoprecipitation_NNP and_CC immunoblotting_VBG
          Protein_NNP lysates_NNS for_IN immunoblotting_VBG were_VBD prepared_VBN by_IN
          bead_NN lysis_NNS in_IN a_DT Fastprep_NNP device_NN (_( Bio_NNP 101_CD )_) in_IN the_DT presence_NN
          of_IN proteinase_NN inhibitors_NNS ,_, followed_VBN by_IN boiling_VBG in_IN SDS_NNP
          sample_NN buffer_NN ._. Cell_NNP lysates_NNS for_IN small_JJ scale_NN
          immunoprecipitations_NNS were_VBD prepared_VBN by_IN disrupting_VBG cells_NNS in_IN
          immunoprecipitation_NN buffer_NN (_( 20_CD mM_NN Tris_NNP /_NN HC_NNP 1_CD ,_, pH_NN 7_CD ._. 4_LS ;_: 150_CD mM_NN
          NaC_NNP 1_CD ;_: 0_CD ._. 5_CD %_NN Triton_NNP X-_NNP 100_CD ,_, 10_CD ug_NN /_NN ml_NN leupeptin_NN ,_, 10_CD ug_NN /_NN ml_NN
          pepstatin_NN ,_, 17_CD ug_NN /_NN ml_NN aprotinin_NN ,_, 1_CD mM_NN PMSF_NNP )_) ._. Lysates_NNP were_VBD
          cleared_VBN and_CC precipitated_VBD with_IN the_DT respective_JJ antisera_NN ._.
          Immunocomplexes_NNP were_VBD collected_VBN by_IN binding_JJ to_TO protein_NN A_DT or_CC
          G_NNP beads_NNS ,_, washed_VBN and_CC analyzed_VBN by_IN immunoblotting_VBG as_IN
          described_VBN [_NN 37_CD ]_NN ._.
          Large_JJ scale_NN lysates_NNS for_IN gel_NN filtration_NN and_CC subsequent_JJ
          immunoprecipitation_NN were_VBD obtained_VBN by_IN bead_NN beater_NN lysis_NNS ._.
          Approximately_RB 5_CD mg_NN of_IN total_JJ cell_NN lysates_NNS was_VBD separated_VBN by_IN
          gel_NN filtration_NN on_IN a_DT 16_CD /_NN 60_CD S_NNP 300_CD column_NN (_( Amersham_NNP Pharmacia_NNP
          Biotech_NNP )_) ,_, and_CC 1_CD ml_NN fractions_NNS were_VBD immunoprecipitated_JJ with_IN
          Pip_NNP 1_CD p_NN antibodies_NNS ._. Precipitates_NNP were_VBD fractionated_JJ by_IN SDS_NNP
          PAGE_NNP and_CC assayed_JJ by_IN immunoblotting_VBG with_IN the_DT respective_JJ
          antisera_NN ._.
        
        
          Indirect_JJ immunofluorescence_NN
          Indirect_JJ immunofluorescence_NN staining_VBG was_VBD performed_VBN
          exactly_RB as_IN described_VBN [_NN 25_CD ]_NN ._.
        
        
          In_IN vitroubiquitylation_NN assay_NN
          For_IN ubiquitylation_NN reactions_NNS ,_, Pip_NNP 1_CD p_NN complexes_NNS were_VBD
          immunoprecipitated_JJ from_IN 100_CD -_: 200_CD ug_NN total_JJ cell_NN lysates_NNS
          prepared_VBN as_IN described_VBN above_IN ._. Precipitates_NNP were_VBD washed_VBN
          four_CD times_NNS in_IN 20_CD mM_NN Tris_NNP /_NN HCI_NNP ,_, pH_NN 7_CD ._. 4_CD ;_: 150_CD mM_NN NaCl_NNP ;_: 0_CD ._. 5_CD %_NN
          Triton_NNP X-_NNP 100_CD ,_, 10_CD μg_NN /_NN ml_NN leupeptin_NN ,_, 10_CD μg_NN /_NN ml_NN pepstatin_NN ,_, 5_CD
          μg_NN /_NN ml_NN aprotinin_NN ,_, 1_CD mM_NN PMSF_NNP ,_, and_CC equilibrated_JJ in_IN 20_CD mM_NN
          HEPES_NNP ,_, pH_NN 7_CD ._. 4_CD ,_, 100_CD mM_NN potassium_NN acetate_NN ,_, 1_CD mM_NN DTT_NNP ._. A_DT
          cocktail_NN was_VBD added_VBN that_IN contained_VBD 8_CD μM_NN ubiquitin_NN ,_, ATP_NNP
          regenerating_VBG system_NN (_( 2_CD mM_NN HEPES_NNP at_IN pH_NN 7_CD ._. 4_CD ,_, 1_CD mM_NN ATP_NNP ,_, 30_CD
          mM_NN creatine_NN phosphate_NN ,_, 1_CD mM_NN magnesium_NN acetate_NN ,_, 0_CD ._. 15_CD mg_NN /_NN ml_NN
          creatine_NN kinase_NN )_) ,_, reaction_NN buffer_NN (_( 4_CD mM_NN magnesium_NN
          acetate_NN ,_, 1_CD mM_NN DTT_NNP )_) ,_, 500_CD nM_NN bacterially_RB expressed_VBD 6_CD ×_NN
          His-_NNP UBCs_NNP ,_, 100_CD nM_NN 6_CD ×_NN His-tagged_NNP human_JJ E_NNP 1_CD ,_, 0_CD ._. 5_CD μM_NN
          ubiquitin_NN aldehyde_NN in_IN a_DT volume_NN of_IN 15_CD ul_NN ._. The_DT reaction_NN was_VBD
          started_VBN by_IN addition_NN of_IN phosphorylated_JJ Rum_NNP 1_CD p_NN ._. After_IN 90_CD min_NN
          at_IN 30_CD °_NN C_NNP ,_, the_DT reaction_NN was_VBD terminated_VBN by_IN the_DT addition_NN 5_CD ×_NN
          SDS_NNP sample_NN buffer_NN ._. Samples_NNP were_VBD separated_JJ on_IN 11_CD %_NN
          SDS-polyacrylamide_NNP gels_NNS and_CC analyzed_VBN by_IN
          autoradiography_NN ._.
          Substrate-independent_NNP 
          in_IN vitro_NN ubiquitylation_NN activity_NN
          was_VBD determined_VBN by_IN immunoprecipitating_VBG Pop_NNP 1_CD p-_NN 13_CD Myc_NNP or_CC
          Pop_NNP 2_CD p-_NN 13_CD Myc_NNP with_IN Myc_NNP antibodies_NNS ._. The_DT same_JJ cocktail_NN as_IN
          described_VBN above_IN was_VBD added_VBN to_TO the_DT precipitates_NNS ._. Reaction_NNP
          products_NNS were_VBD determined_VBN by_IN immunoblotting_VBG with_IN ubiquitin_NN
          antibodies_NNS (_( Zymed_NNP )_) ._.
        
        
          Subcellular_NNP fractionation_NN
          Cells_NNP grown_VBN in_IN YES_NNP were_VBD harvested_VBN and_CC washed_VBN in_IN buffer_NN
          S_NNP (_( 1_CD ._. 4_LS M_NNP sorbitol_NN ,_, 40_CD mM_NN HEPES_NNP (_( pH_NN =_SYM 7_CD ._. 2_LS )_) ,_, 0_CD ._. 5_CD mM_NN MgCl_NNP 
          2_LS )_) ._. Cells_NNP were_VBD resuspended_JJ in_IN buffer_NN
          S_NNP ,_, 1_CD mM_NN PMSF_NNP ,_, 10_CD mM_NN β-mercaptoethanol_JJ and_CC incubated_JJ for_IN
          10_CD min_NN at_IN 30_CD °_NN C_NNP ._. Cells_NNP were_VBD pelleted_JJ ,_, resuspended_JJ in_IN 4_CD
          pellet_NN volumes_NNS of_IN buffer_NN S_NNP ,_, 1_CD mM_NN PMSF_NNP ,_, Zymolyase_NNP (_( 100_CD
          ug_NN /_NN ml_NN )_) and_CC incubated_JJ at_IN 30_CD °_NN C_NNP for_IN 40_CD min_NN ._. Cells_NNP were_VBD
          diluted_VBN in_IN buffer_NN S_NNP and_CC pelleted_JJ by_IN centrifugation_NN and_CC
          resuspended_JJ in_IN buffer_NN F_NN (_( 18_CD %_NN Ficoll_NNP 400_CD ,_, w_NN /_NN v_NN ;_: 20_CD mM_NN
          HEPES_NNP (_( pH_NN =_SYM 7_CD ._. 2_LS )_) ,_, 0_CD ._. 5_CD mM_NN MgCl_NNP 
          2_CD and_CC protease_NN inhibitors_NNS ._. Cells_NNP were_VBD
          lysed_JJ by_IN homogenization_NN using_VBG a_DT teflon_NN pestel_NN fitted_JJ into_IN
          a_DT microfuge_NN tube_NN ._. Cell_NNP lysis_NNS was_VBD monitored_VBN by_IN microscopy_NN ._.
          Unlysed_NNP cells_NNS were_VBD pelleted_JJ by_IN gentle_JJ centrifugation_NN ._. The_DT
          lysate_NN was_VBD placed_VBN on_IN top_NN of_IN buffer_NN GF_NNP (_( 7_CD %_NN Ficoll_NNP 400_CD ,_,
          w_NN /_NN v_NN ,_, 20_CD %_NN glycerol_NN ,_, 20_CD mM_NN HEPES_NNP (_( pH_NN =_SYM 7_CD ._. 2_LS )_) ,_, 0_CD ._. 5_CD mM_NN MgCl_NNP 
          2_LS )_) ._. Nuclei_NNP were_VBD pelleted_JJ by_IN spinning_JJ
          at_IN 7000_CD rpm_NN in_IN a_DT microfuge_NN ._. The_DT cytoplasmic_JJ fraction_NN was_VBD
          removed_VBN and_CC mixed_VBN with_IN SDS_NNP sample_NN buffer_NN ._. The_DT nuclear_JJ
          pellet_NN was_VBD resolved_VBN in_IN an_DT equal_JJ volume_NN of_IN SDS_NNP sample_NN
          buffer_NN ._. Fractions_NNP were_VBD analyzed_VBN by_IN immunoblotting_VBG as_IN
          described_VBN in_IN Fig_NNP ._. 3_LS ._.
        
      
      
        Abbreviations_NNP
        SCF_NNP :_: SKP_NNP 1_CD /_NN CUL_NNP 1_CD /_NN F-_NNP box_NN protein_NN
        UBC_NNP :_: ubiquitin-conjugating_JJ enzyme_NN
        HA_NNP :_: hemagglutinin_NN
        NLS_NNP :_: nuclear_JJ localization_NN signal_NN
        NES_NNP :_: nuclear_JJ export_NN signal_NN
      
      
        Authors_NNP '_'' contributions_NNS
        All_DT experiments_NNS were_VBD performed_VBN by_IN VS_NNP ._. with_IN the_DT following_JJ
        exceptions_NNS :_: Building_NNP on_IN reagents_NNS prepared_VBN by_IN VS_NNP ._. ,_, CP_NNP ._.
        performed_VBD the_DT experiments_NNS shown_VBN in_IN Figs_NNP ._. 2_LS B_NNP ,_, 4_CD A_DT ,_, and_CC 7_CD ._. IS_VBZ ._.
        performed_VBD the_DT experiments_NNS shown_VBN in_IN Fig_NNP ._. 4_LS D_NNP ,_, 5_CD ,_, and_CC 6_CD A_DT ._. ER_NNP ._.
        performed_VBD the_DT immunostaining_VBG experiments_NNS shown_VBN in_IN Fig_NNP ._.
        3_LS Cand_NNP 3_CD E_NNP ._. RL_NNP ._. performed_VBD the_DT experiment_NN shown_VBN in_IN Fig_NNP ._. 3_LS Aand_NNP
        contributed_VBD data_NNS not_RB shown_VBN ._. KA_NNP ._. produced_VBN recombinant_JJ UBCs_NNP
        used_VBD in_IN Fig_NNP ._. 2_LS D_NNP ._. CZ_NNP ._. prepared_VBD the_DT 
        csn_NN 5_CD mutant_JJ used_VBN in_IN Fig_NNP ._. 2_LS D_NNP ,_,
        contributed_VBD to_TO the_DT preparation_NN of_IN SCF_NNP Popantisera_NNP used_VBD in_IN
        Figs_NNP ._. 1_LS ,_, 2_CD D_NNP ,_, and_CC 7_CD ,_, and_CC assisted_VBN with_IN study_NN design_NN ._. DAW_NNP ._.
        performed_VBD the_DT experiment_NN in_IN Fig_NNP ._. 6_CD B_NNP ,_, conceived_VBD the_DT study_NN ,_,
        drafted_VBD the_DT manuscript_NN ,_, and_CC participated_VBD in_IN study_NN design_NN
        and_CC coordination_NN ._. All_DT authors_NNS read_VBP and_CC approved_VBD the_DT final_JJ
        manuscript_NN ._.
      
    
  
